5 results  1 of 1 

1 Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver Diseases
Nobuharu Tamaki, Masayuki Kurosaki, Rohit Loomba, Namiki Izumi
Ann Lab Med.2021;41(1):16-24.   Published online 2021 January 1     DOI: http://dx.doi.org/10.3343/alm.2021.41.1.16
      
2 Durability of Sustained Virologic Response and Improvement of Fibrosis Markers after Daclatasvir and Asunaprevir Treatment in Genotype 1b Hepatitis C Virus-Infected Patients: a Real Life and Multicenter Study
Seung Kak Shin, Jin-Woo Lee, Hannah Ra, Oh Sang Kwon, Jong-Beom Shin, Young-Joo Jin, Sangheun Lee, Ki Jun Han, Young Nam Kim, Tae Hun Kim, Yun Soo Kim, Ju Hyun Kim
J Korean Med Sci.2019;34(41):e264.  Published online 2019 September 30     DOI: http://dx.doi.org/10.3346/jkms.2019.34.e264
      
3 The Efficacy and Safety of Direct-acting Antiviral Treatment for Chronic Hepatitis C Patients: A Single Center Study
Seong Jun Park, Ah Ran Kim, Won Hyeok Choe, Jeong Han Kim, Byung Chul Yoo, So Young Kwon
Korean J Gastroenterol.2018;72(4):197-204.   Published online 2018 October 30     DOI: http://dx.doi.org/10.4166/kjg.2018.72.4.197
      
4 Durability of Sustained Virologic Response in Chronic Hepatitis C: Analysis of Factors Related to Relapse after Sustained Virologic Response with Peginterferon Plus Ribavirin Combination Therapy
Jang Eun Lee, Na Ri Yoon, Jin Dong Kim, Myeong Jun Song, Jung Hyun Kwon, Si Hyun Bae, Jong Young Choi, Sung Won Jeong, Seung Kew Yoon
Korean J Gastroenterol.2011;57(3):173-179.   Published online 2011 March 31     DOI: http://dx.doi.org/10.4166/kjg.2011.57.3.173
      
5 The Effectiveness of Combination Therapy with Peginterferon α-2a and Ribavirin in Chronic Hepatitis C
Yeon-Joo Kim, Young-Il Kim, Young-A Song, Nam-Cheol Jin, Sung-Ryoun Lim, Dae-Yeul Ryang, Kyoung-Myeun Chung, Seon-Young Park, Chang-Hwan Park, Hyun-Soo Kim, Sung-Kyu Choi, Jong-Sun Rew
Chonnam Med J.2008;44(2):72-81.   Published online 2008 August 31     DOI: http://dx.doi.org/10.4068/cmj.2008.44.2.72
      

 1 of 1